Literature DB >> 8840287

Effect of the dialysis membrane on mortality of chronic hemodialysis patients.

R M Hakim1, P J Held, D C Stannard, R A Wolfe, F K Port, J T Daugirdas, L Agodoa.   

Abstract

Mortality of prevalent chronic hemodialysis patients remains high. The potential effect of the dialysis membrane on this mortality has not been previously investigated in a large population of chronic hemodialysis patients. Using data from the United States Renal Data System (USRDS), we analyzed a random sample of 6,536 patients receiving hemodialysis on December 31, 1990. The study design was a historical prospective study. By limiting the study to patients dialyzed for at least one year with bicarbonate dialysate, in whom the dose of dialysis could be calculated, and in whom dialysis membrane and co-existing morbidities were defined, the sample size was reduced to 2,410 patients. A Cox proportional hazards model was used to estimate relative mortality risk. The types of dialysis membranes used were broadly classified into three categories: unsubstituted cellulose, modified cellulose (generally cellulose membranes that have been modified by substitutions of some or most of their hydroxyl moieties) and synthetic membranes that are not cellulose-based. The results of the study suggest that after adjusting for the dose of dialysis and the presence of co-morbid factors, the relative risk of mortality of patients dialyzed with modified cellulose or synthetic membranes was at least 25% less than that of patients treated with unsubstituted cellulose membranes (P < 0.001). To account for the possibility that these differences were due to regional practice patterns, we further stratified the data for nine different regions. There was still a 20% difference in relative risk of mortality between membrane groups with the mortality statistically significantly less in patients treated with synthetic membranes (P < 0.045) compared to patients dialyzed with unsubstituted cellulose membranes. The results of this study suggest that the dialysis membrane plays an important role in the outcome of chronic hemodialysis patients. However, more definitive studies are needed before a cause and effect relationship can be proven.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8840287     DOI: 10.1038/ki.1996.350

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  14 in total

1.  Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRD.

Authors:  Francesco Locatelli; Paolo Altieri; Simeone Andrulli; Piergiorgio Bolasco; Giovanna Sau; Luciano A Pedrini; Carlo Basile; Salvatore David; Mariano Feriani; Giovanni Montagna; Biagio Raffaele Di Iorio; Bruno Memoli; Raffaella Cravero; Giovanni Battaglia; Carmine Zoccali
Journal:  J Am Soc Nephrol       Date:  2010-09-02       Impact factor: 10.121

Review 2.  High-flux versus low-flux membranes for end-stage kidney disease.

Authors:  Suetonia C Palmer; Kannaiyan S Rabindranath; Jonathan C Craig; Paul J Roderick; Francesco Locatelli; Giovanni F M Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

3.  Practice patterns, case mix, Medicare payment policy, and dialysis facility costs.

Authors:  R A Hirth; P J Held; S M Orzol; A Dor
Journal:  Health Serv Res       Date:  1999-02       Impact factor: 3.402

4.  Performance and Hemocompatibility of a Novel Polysulfone Dialyzer: A Randomized Controlled Trial.

Authors:  Götz Ehlerding; Ansgar Erlenkötter; Adelheid Gauly; Bettina Griesshaber; James Kennedy; Lena Rauber; Wolfgang Ries; Hans Schmidt-Gürtler; Manuela Stauss-Grabo; Stephan Wagner; Adam M Zawada; Sebastian Zschätzsch; Manuela Kempkes-Koch
Journal:  Kidney360       Date:  2021-04-07

Review 5.  Water quality in conventional and home haemodialysis.

Authors:  Matthew J Damasiewicz; Kevan R Polkinghorne; Peter G Kerr
Journal:  Nat Rev Nephrol       Date:  2012-10-23       Impact factor: 28.314

6.  Greater first-year survival on hemodialysis in facilities in which patients are provided earlier and more frequent pre-nephrology visits.

Authors:  Takeshi Hasegawa; Jennifer L Bragg-Gresham; Shin Yamazaki; Shunichi Fukuhara; Tadao Akizawa; Werner Kleophas; Roger Greenwood; Ronald L Pisoni
Journal:  Clin J Am Soc Nephrol       Date:  2009-03-04       Impact factor: 8.237

7.  Immunologic function and survival in hemodialysis patients.

Authors:  P L Kimmel; T M Phillips; S J Simmens; R A Peterson; K L Weihs; S Alleyne; I Cruz; J A Yanovski; J H Veis
Journal:  Kidney Int       Date:  1998-07       Impact factor: 10.612

8.  Surface characterization of dialyzer polymer membranes by imaging ToF-SIMS and quantitative XPS line scans.

Authors:  Markus Holzweber; Andreas Lippitz; Katharina Krueger; Joachim Jankowski; Wolfgang E S Unger
Journal:  Biointerphases       Date:  2015-03-24       Impact factor: 2.456

Review 9.  Biocompatible hemodialysis membranes for acute renal failure.

Authors:  A Alonso; J Lau; B L Jaber
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23

Review 10.  Toward engineering a novel transplantation site for human pancreatic islets.

Authors:  Alexandra M Smink; Marijke M Faas; Paul de Vos
Journal:  Diabetes       Date:  2013-05       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.